๐ŸŽ Black Friday: up to 50% off of annual plans
Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE ยท Real-Time Price ยท USD
31.37
-1.06 (-3.27%)
Nov 20, 2026, 4:00 PM EST - Market closed

Maze Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
20-167.5--
Revenue Growth
-----
Gross Profit
20-167.5--
Operating Income
-164.16-142.957.59-98.55-111.03
Net Income
-151.47-131.123.41-100.42-114.94
Earnings Per Share
-2.67-3.051.25-43.89-57.18
EPS Growth
-----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
476.98341.92196.8129.1699.92
Total Debt
59.6423.3126.6349.6232.06
Net Cash (Debt)
417.34318.61170.18-20.4767.86
Net Cash Growth
16.01%87.22%---
Net Cash Per Share
7.347.4162.33-8.9433.76

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-114.74-111.9475.95-86.83-99.2
Capital Expenditures
-0.52-0.79-1.15-0.44-1.97
Free Cash Flow
-115.26-112.7374.81-87.27-101.17
Free Cash Flow Growth
-----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
100.00%-100.00%--
Operating Margin
-820.82%-34.38%--
Pretax Margin
-757.36%-31.88%--
Profit Margin
-757.36%-2.03%--
FCF Margin
-576.30%-44.66%--

Valuation

Selected indicators aren't available for this stock.